PHARMAKAISER GRIVEGNEE

Liège ·KBO/BCE: BE 0774.285.474

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	17-06-2025	44 d early	2025-00147200
31-12-2023	31-07-2024	29-07-2024	2 d early	2024-00306537
31-12-2022	31-07-2023	02-08-2023	2 d late	2023-00319256

Metric	This company	Sector median	Position in the sector
Solvency	60.1%	17.3%	better than 86% of 866 sector peers
Net result	€-4k	€14k	better than 31% of 867 sector peers
Equity	€329k	€100k	better than 73% of 868 sector peers
Gross operating margin	€196k	€213k	better than 48% of 794 sector peers
Staff costs	€171k	€219k	higher than 42% of 715 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€547k
Fixed assets	21/28	€187k
Tangible fixed assets	22/27	€186k
Financial fixed assets	28	€260
Current assets	29/58	€360k
Stocks & contracts in progress	3	€100k
Amounts receivable within one year	40/41	€169k
Investments	50/53	€0
Cash & bank	54/58	€78k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€547k
Equity	10/15	€329k
Contributions / capital	10/11	€176k
Reserves	13	€157k
Accumulated profits (losses)	14	€-4k
Amounts payable	17/49	€218k
Amounts payable after one year	17	€123k
Amounts payable within one year	42/48	€94k
Trade debts payable within one year	44	€62k
Income statement
Gross operating margin	9900	€196k
Operating result	9901	€8k
Financial income	75	€3k
Financial charges	65	€15k
Result before taxes	9903	€-4k
Net result for the period	9904	€-4k
Result to be appropriated	9905	€-4k

Summary